Synapse and FDA collaborate to swiftly generate real-world data (RWD) in COVID-19 patients with cancer

The collaboration is already yielding useful results and aims to tackle the following:

  • Investigating methods to derive RWD from multiple sources including electronic health records, registries and molecular data
  • Enhancing understanding of how patients respond to therapies outside of clinical trials to improve care and outcomes
  • Understanding the impact of COVID-19 on cancer care

Click here to learn more

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: SEP2020BR001